Perspective Therapeutics, Inc. (CATX)

NYSEAMERICAN: CATX · Real-Time Price · USD

2.570

-0.130 (-4.81%)

At close: May 30, 2025, 4:00 PM

2.570

0.00 (0.00%)

After-hours: May 30, 2025, 8:00 PM EDT

Perspective Therapeutics Market Cap

Perspective Therapeutics has a market cap or net worth of $190.31 million as of May 30, 2025. Its market cap has decreased by -81.36% in one year.

Market Cap

190.31M

Enterprise Value

-17.94M

1-Year Change

-81.36%

Ranking

#3666

Market Cap Chart

Since November 10, 2005, Perspective Therapeutics's market cap has increased from $49.80M to $190.31M, an increase of 282.15%. That is a compound annual growth rate of 7.09%.

Market Cap History

Date	Market Cap	% Change
May 29, 2025	200.40M	-7.05%
Dec 31, 2024	215.60M	91.13%
Dec 29, 2023	112.80M	221.37%
Dec 30, 2022	35.10M	-36.18%
Dec 31, 2021	55.00M	39.95%
Dec 31, 2020	39.30M	-6.65%
Dec 31, 2019	42.10M	108.42%
Dec 31, 2018	20.20M	-8.18%
Dec 29, 2017	22.00M	-31.03%
Dec 30, 2016	31.90M	-38.18%
Dec 31, 2015	51.60M	-35.58%
Dec 31, 2014	80.10M	317.19%
Dec 31, 2013	19.20M	-28.89%
Dec 31, 2012	27.00M	41.36%
Dec 30, 2011	19.10M	-28.20%
Dec 31, 2010	26.60M	30.39%
Dec 31, 2009	20.40M	343.48%
Dec 31, 2008	4.60M	-90.09%
Dec 31, 2007	46.40M	-40.28%
Dec 29, 2006	77.70M	9.75%
Dec 30, 2005	70.80M	42.17%

View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	648.68B
Johnson & Johnson	369.52B
AbbVie	327.88B
Novo Nordisk	305.07B
UnitedHealth Group	270.48B
Abbott Laboratories	231.10B
Novartis AG	219.70B
AstraZeneca	216.88B

Market Cap Rankings